ID | Name | Number of studies | |
---|---|---|---|
CL_0000164 | enteroendocrine cell | 18 | |
CL_0000169 | type B pancreatic cell | 5 | |
CL_0000173 | pancreatic D cell | 4 | |
CL_0000171 | pancreatic A cell | 4 | |
CL_0002275 | pancreatic PP cell | 3 | |
CL_0005019 | pancreatic epsilon cell | 2 | |
CL_0000504 | enterochromaffin-like cell | 1 | |
CL_0000696 | PP cell | 0 | |
CL_0000502 | type D enteroendocrine cell | 0 | |
CL_0002067 | type A enteroendocrine cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
FEV | 6 | 48% ± 21% | 0 | 1 | |
CRYBA2 | 6 | 42% ± 19% | 0 | 1 | |
SCGN | 6 | 63% ± 26% | 0 | 4 | |
INSM1 | 5 | 53% ± 20% | 0 | 0 | |
RFX6 | 4 | 43% ± 22% | 0 | 0 | |
GHRL | 3 | 32% ± 10% | 0 | 0 | |
CHGA | 7 | 67% ± 21% | 1 | 9 | |
NEUROD1 | 6 | 55% ± 19% | 1 | 8 | |
NKX2-2 | 5 | 41% ± 18% | 1 | 3 | |
SCT | 4 | 39% ± 9% | 1 | 1 | |
REG4 | 4 | 27% ± 6% | 1 | 1 | |
VWA5B2 | 4 | 38% ± 23% | 1 | 2 | |
GUCY2C | 4 | 43% ± 19% | 1 | 2 | |
MS4A8 | 4 | 69% ± 13% | 1 | 3 | |
CHGB | 5 | 50% ± 23% | 1 | 14 | |
RAB3B | 4 | 52% ± 19% | 1 | 6 | |
FOXA3 | 3 | 19% ± 4% | 1 | 1 | |
SMIM6 | 3 | 39% ± 13% | 1 | 2 | |
SLC29A4 | 3 | 36% ± 13% | 1 | 2 | |
KIF12 | 3 | 29% ± 7% | 1 | 4 | |
PCSK1 | 3 | 30% ± 6% | 1 | 4 | |
SSTR2 | 3 | 23% ± 4% | 1 | 4 | |
SYT13 | 3 | 31% ± 8% | 1 | 5 | |
RAB26 | 5 | 39% ± 19% | 2 | 2 | |
DDC | 5 | 42% ± 19% | 2 | 5 | |
HEPACAM2 | 4 | 42% ± 15% | 2 | 5 | |
RIMBP2 | 4 | 45% ± 18% | 2 | 8 | |
PHGR1 | 7 | 60% ± 33% | 3 | 9 | |
LGALS4 | 6 | 57% ± 30% | 3 | 8 | |
SCG2 | 6 | 43% ± 18% | 3 | 12 |
GO_0010609 | Biological process | mRNA localization resulting in post-transcriptional regulation of gene expression |
GO_0003309 | Biological process | type B pancreatic cell differentiation |
GO_0006182 | Biological process | cGMP biosynthetic process |
GO_1900118 | Biological process | negative regulation of execution phase of apoptosis |
GO_0009072 | Biological process | aromatic amino acid metabolic process |
GO_0002029 | Biological process | desensitization of G protein-coupled receptor signaling pathway |
GO_0002576 | Biological process | platelet degranulation |
GO_0043043 | Biological process | peptide biosynthetic process |
GO_0003310 | Biological process | pancreatic A cell differentiation |
GO_0021530 | Biological process | spinal cord oligodendrocyte cell fate specification |
GO_2000121 | Biological process | regulation of removal of superoxide radicals |
GO_0140115 | Biological process | export across plasma membrane |
GO_0048241 | Biological process | epinephrine transport |
GO_0061101 | Biological process | neuroendocrine cell differentiation |
GO_0051620 | Biological process | norepinephrine uptake |
GO_0016554 | Biological process | cytidine to uridine editing |
GO_0001692 | Biological process | histamine metabolic process |
GO_0046654 | Biological process | tetrahydrofolate biosynthetic process |
GO_2000623 | Biological process | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0006837 | Biological process | serotonin transport |
GO_0045838 | Biological process | positive regulation of membrane potential |
GO_0071377 | Biological process | cellular response to glucagon stimulus |
GO_0016556 | Biological process | mRNA modification |
GO_0051608 | Biological process | histamine transport |
GO_0060290 | Biological process | transdifferentiation |
GO_0003358 | Biological process | noradrenergic neuron development |
GO_0042427 | Biological process | serotonin biosynthetic process |
GO_0021522 | Biological process | spinal cord motor neuron differentiation |
GO_0051615 | Biological process | histamine uptake |
GO_0030858 | Biological process | positive regulation of epithelial cell differentiation |
Cell type name | enteroendocrine cell |
Synonyms | |
Description | An endocrine cell that is located in the epithelium of the gastrointestinal tract or in the pancreas. |
Parent | CL_0000150 |